In late December 2014, OTCPharm Public Company, a subsidiary of Pharmstandard JSC, announced a successful completion of the procedure for listing of its shares. The project was supported by the Banking & Finance and Capital Markets Team at EPAM.

The deal structure provided for two stages: spining-off of a subsidiary from Pharmstandard JSC, involving a transfer of the company’s OTC business, as well as further listing of shares in the newly established company in order to  prepare for an eventual IPO.

Under this project, the Firm’s lawyers have provided legal support of the share issue registration during the restructuring of Pharmstandard JSC, including further registration of the prospectus, and have drafted documents required to undergo the listing procedure.

As a result, the shares in OTCPharm Public Company have been put on the second tier of MICEX Quotation List, and as a consequence, all conditions were provided to further list the securities abroad.

The deal was supported by the Banking & Finance and Capital Markets Team of EPAM, including Associate Alexander Filchukov, supervised by Partner and Head of the Practice Dmitriy Glazounov.